| Financial Year |
March 31 2023 |
| Monetary Funds |
1,412,968,938.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,218,822.99 |
| Accounts Receivable |
88,155,118.40 |
| Advances to Suppliers |
18,114,750.67 |
| Other Receivables |
844,146.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
141,083,869.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,026,972.42 |
| Total Current Assets |
1,684,412,619.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
29,745,323.56 |
| Fixed Assetes |
293,143,989.69 |
| Under-construction Projects |
212,451,387.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,320,147.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,857,546.38 |
| Deferred Income Tax Assets |
3,749,636.87 |
| Other Non-Current Assets |
56,159,658.84 |
| Sub-Total of Non-Current Assets |
671,427,690.94 |
| Total Assets |
2,355,840,310.21 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,053,365.00 |
| Accounts Payable |
92,716,358.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
775,963.56 |
| Taxes Payable |
1,739,518.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,235,817.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
114,021,894.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,714,678.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,928,142.50 |
| Total Liabilities |
119,950,037.07 |
| Paid-In Capital(Or Share Stock) |
96,696,140.00 |
| Capital Surplus |
1,750,774,157.68 |
| Surplus Reserve |
46,880,147.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
339,888,028.55 |
| Minority Stockholder's Interest |
1,651,798.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,234,238,474.18 |
| Owner's Equity（Stockholder's Equity） |
2,235,890,273.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,355,840,310.21 |
